Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
RELA | hg38_v1_chr11_-_65662931_65662972 | 0.63 | 1.1e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_9760893 Show fit | 16.92 |
ENST00000228434.7
ENST00000536709.1 |
CD69 molecule |
|
chr4_-_76023489 Show fit | 14.79 |
ENST00000306602.3
|
C-X-C motif chemokine ligand 10 |
|
chr6_-_31582415 Show fit | 12.39 |
ENST00000429299.3
ENST00000446745.2 |
lymphotoxin beta |
|
chr2_-_89143133 Show fit | 12.36 |
ENST00000492167.1
|
immunoglobulin kappa variable 3-20 |
|
chr6_+_137867241 Show fit | 11.78 |
ENST00000612899.5
ENST00000420009.5 |
TNF alpha induced protein 3 |
|
chr6_+_137867414 Show fit | 10.30 |
ENST00000237289.8
ENST00000433680.1 |
TNF alpha induced protein 3 |
|
chr11_+_102317450 Show fit | 9.81 |
ENST00000615299.4
ENST00000527309.2 ENST00000526421.6 ENST00000263464.9 |
baculoviral IAP repeat containing 3 |
|
chr6_+_144150492 Show fit | 9.65 |
ENST00000367568.5
|
syntaxin 11 |
|
chr11_+_102317542 Show fit | 9.23 |
ENST00000532808.5
|
baculoviral IAP repeat containing 3 |
|
chr1_-_186680411 Show fit | 9.09 |
ENST00000367468.10
|
prostaglandin-endoperoxide synthase 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 41.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
2.1 | 32.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
1.6 | 27.6 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.3 | 27.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
6.0 | 23.9 | GO:0034147 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
0.2 | 23.7 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
1.7 | 20.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.5 | 19.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
1.9 | 17.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
1.7 | 17.1 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 59.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 54.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 27.6 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
1.4 | 27.1 | GO:0042611 | MHC protein complex(GO:0042611) MHC class II protein complex(GO:0042613) |
0.0 | 18.9 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.5 | 18.4 | GO:0031143 | pseudopodium(GO:0031143) |
1.8 | 17.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.4 | 15.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 12.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 12.7 | GO:0002102 | podosome(GO:0002102) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 41.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
2.9 | 32.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 28.5 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.6 | 26.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
5.2 | 25.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.5 | 24.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.1 | 22.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
2.6 | 20.9 | GO:0046979 | TAP2 binding(GO:0046979) |
1.1 | 18.5 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.2 | 12.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 86.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 36.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 34.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 31.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 29.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
1.1 | 24.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 23.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 17.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 13.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 11.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 77.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.9 | 55.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.8 | 27.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 24.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 16.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.4 | 15.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.6 | 14.7 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.3 | 14.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 14.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.6 | 14.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |